Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corpora...

Symbol: MURA
22 days ago

Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027

Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential business...

Symbol: ETST
22 days ago

Option Care Health Announces Chief Financial Officer Transition

Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025 Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named ...

Symbol: OPCH
22 days ago

Guess?, Inc. to Release Second Quarter Fiscal 2026 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Guess?, Inc. (NYSE: GES) will release its financial results for the second quarter of fiscal year 2026, which ended August 2, 2025, on Wednesday, August 27, 2025. The ...

Symbol: GES
22 days ago

Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology

Notice of Allowance marks first Chinese patent to be issued on Anixa Breast Cancer Vaccine Expands global intellectual property coverage in markets with high breast cancer incidence New patent will...

Symbol: ANIX
22 days ago

ELTA North America Awarded $5 Million Contract to Provide Counter Drone Systems

ANNAPOLIS JUNCTION, Md., Aug. 20, 2025 /PRNewswire/ -- ELTA North America, headquartered in Maryland, continues to set the standard in Air and Ground-Based Integrated Sensor solutions. As part of i...

Symbol: IAI
22 days ago

Elysium Therapeutics Completes Pre-IND Meeting with FDA for First-Ever Technology Designed to Combat Oral Fentanyl Overdose

Reports alignment with FDA on next steps to progress clinical program for SOOPR™ as a potentially novel rescue therapy for oral fentanyl overdose LYONS, Colo., Aug. 20, 2025 /PRNewswire/ -- Elysium...

Symbol: ELYS
22 days ago